Investors that have room in their portfolio for some new additions might want to check out the three ASX 200 stocks named in this article.
As well as being high quality options, they have been identified as buys by leading brokers and tipped to rise nicely from where they trade today.
Let's see what analysts are saying about these top stocks right now:
CSL Limited (ASX: CSL)
CSL could be a top ASX 200 stock to buy this week. It is one of the world's leading biotechnology companies, comprising the CSL Behring, CSL Vifor, and CSL Seqirus businesses. These are the leaders in their respective fields of plasma therapies, iron deficiency and nephrology, and influenza vaccines.
CSL is arguably one of the highest quality companies that Australia has to offer and appears well-positioned for growth in the coming years. This is thanks to its world class product portfolio, strong demand for immunoglobulins, and its burgeoning research and development pipeline.
Analysts at Macquarie are very positive on the company and are expecting strong earnings growth for the foreseeable future. In light of this, the broker has put an outperform rating and $330.00 price target on its shares. Though, it also sees potential for its shares to rise beyond $500.00 in the coming years.
Goodman Group (ASX: GMG)
Another ASX 200 stock that could be a great option for investors this week is Goodman Group.
It is a specialist global industrial property and digital infrastructure company that owns, develops, and manages high quality sustainable properties that are close to consumers and provide essential infrastructure for the digital economy.
The team at Citi is very positive on the company's outlook and expects its strong earnings growth to continue over the medium term.
As a result, the broker recently put a buy rating and $40.00 price target on its shares.
Qantas Airways Limited (ASX: QAN)
Finally, analysts at Goldman Sachs think that investors should be buying this airline operator's shares this week.
This is because the broker believes that this ASX 200 stock is undervalued compared to its US peers. Especially given its structurally stronger earnings following a post-COVID transformation.
Another positive is that the broker believes that Qantas' dividends will return in FY 2025 after being suspended since COVID.
In light of the above, the broker has put Qantas' shares on its coveted conviction list with a buy rating and $8.05 price target.
